October 29, 2026

Medical Oddities: The ghost that haunted a heart

From haunted hearts to toxic treats, medicine has a few Halloween tricks up its sleeve.

MDSpire News

October 21, 2026

Doctor convicted in 2 million–pill stimulant scheme

The physician claimed he could diagnose ADHD with 1 question and reported having more than 3,000 patients in 3 states.

MDSpire News

October 15, 2026

Medical Oddities: Alive, but convinced otherwise

A deadly conviction, healing vanilla, stormy lungs, and a COVID tea party await.

MDSpire News

October 09, 2026

FDA approves olanzapine injection for schizophrenia

All 3 monthly doses improved schizophrenia symptoms versus placebo in the phase 3 SOLARIS trial.

MDSpire News

October 08, 2026

FDA flags potential cardiac risk with evenamide

Four deaths among evenamide-treated patients prompted FDA concerns about possible fatal arrhythmias, although a causal link remains unconfirmed.

MDSpire News

September 24, 2026

Alcohol use disorders may predict posttrauma-related CV risk

Among trauma-exposed adults, alcohol use disorders ranked above PTSD, depression, and other psychiatric diagnoses as predictors of major cardiac and cerebrovascular events.

MDSpire News

September 02, 2026

36 genes may reshape OCD, tic genetics

Whole-exome sequencing identifies large-effect risk genes across obsessive-compulsive and chronic tic disorders, with most supported by both conditions.

MDSpire News

August 31, 2026

Emergency diagnosis may flag poor outcomes beyond cancer

Across 13 noncancer conditions, emergency diagnosis was common and associated with higher 1-year mortality.

MDSpire News

August 25, 2026

Volatility priors may reveal delusion severity in schizophrenia

Expectations of environmental instability declined alongside delusional symptoms during 6 months following an acute psychotic episode.

MDSpire News

July 31, 2026

Can SGLT2 Inhibitors Affect Dementia?

A target trial emulation using Veterans Affairs electronic health records examined neuropsychiatric outcomes associated with SGLT2 inhibitor use.

MDSpire News